19 May 2011 11:19

For Immediate Release | 19 May 2011 |
Â
Â
ImmuPharma PLC
Â
Result of Annual General Meeting
Â
Â
ImmuPharma PLC (AIM:IMM), the specialist drug discovery and development company, held its AGM earlier today and is pleased to announce that all resolutions were duly passed.
Â
Â
Â
- End -
Â
Â
For further information please contact:
Â
ImmuPharma PLC:
Dr Robert Zimmer, President & Chief Scientific Officer + 33 389 32 76 50
Dimitri Dimitriou, Chief Executive Officer +44 20 7152 4080
Richard Warr, Chairman +44 20 7152 4080
Â
Buchanan Communications
Lisa Baderoon
Mark Court +44 20 7466 5000
Â
Panmure, Gordon & Co., NOMAD & Broker
Andrew Burnett
Rakesh Sharma +44 20 7459 3600
Â
Espirito Santo Investment Bank
James Bromhead
Richard Crawley +44 20 7456 9191
Â